111 related articles for article (PubMed ID: 28418440)
1. An all-atom molecular dynamics study of the anti-interferon signaling of Ebola virus: interaction mechanisms of EBOV VP24 binding to Karyopherin alpha5.
Ding JN; Zhang YJ; Zhong H; Ao CC; Li J; Han JG
Mol Biosyst; 2017 May; 13(5):1031-1045. PubMed ID: 28418440
[TBL] [Abstract][Full Text] [Related]
2. VP24-Karyopherin Alpha Binding Affinities Differ between Ebolavirus Species, Influencing Interferon Inhibition and VP24 Stability.
Schwarz TM; Edwards MR; Diederichs A; Alinger JB; Leung DW; Amarasinghe GK; Basler CF
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974555
[TBL] [Abstract][Full Text] [Related]
3. Investigating Ebola virus pathogenicity using molecular dynamics.
Pappalardo M; Collu F; Macpherson J; Michaelis M; Fraternali F; Wass MN
BMC Genomics; 2017 Aug; 18(Suppl 5):566. PubMed ID: 28812539
[TBL] [Abstract][Full Text] [Related]
4. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.
Reid SP; Valmas C; Martinez O; Sanchez FM; Basler CF
J Virol; 2007 Dec; 81(24):13469-77. PubMed ID: 17928350
[TBL] [Abstract][Full Text] [Related]
5. Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells.
Feagins AR; Basler CF
Virology; 2015 Nov; 485():145-52. PubMed ID: 26255028
[TBL] [Abstract][Full Text] [Related]
6. Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24.
Ramanathan P; Tigabu B; Santos RI; Ilinykh PA; Kuzmina N; Vogel OA; Thakur N; Ahmed H; Wu C; Amarasinghe GK; Basler CF; Bukreyev A
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243162
[TBL] [Abstract][Full Text] [Related]
7. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation.
Reid SP; Leung LW; Hartman AL; Martinez O; Shaw ML; Carbonnelle C; Volchkov VE; Nichol ST; Basler CF
J Virol; 2006 Jun; 80(11):5156-67. PubMed ID: 16698996
[TBL] [Abstract][Full Text] [Related]
8. Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling.
Mateo M; Reid SP; Leung LW; Basler CF; Volchkov VE
J Virol; 2010 Jan; 84(2):1169-75. PubMed ID: 19889762
[TBL] [Abstract][Full Text] [Related]
9. Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1.
Xu W; Edwards MR; Borek DM; Feagins AR; Mittal A; Alinger JB; Berry KN; Yen B; Hamilton J; Brett TJ; Pappu RV; Leung DW; Basler CF; Amarasinghe GK
Cell Host Microbe; 2014 Aug; 16(2):187-200. PubMed ID: 25121748
[TBL] [Abstract][Full Text] [Related]
10. Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.
Ilinykh PA; Lubaki NM; Widen SG; Renn LA; Theisen TC; Rabin RL; Wood TG; Bukreyev A
J Virol; 2015 Aug; 89(15):7567-83. PubMed ID: 25972536
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the Ebola Virus VP24 Protein by SUMO.
Vidal S; El Motiam A; Seoane R; Preitakaite V; Bouzaher YH; Gómez-Medina S; San Martín C; Rodríguez D; Rejas MT; Baz-Martínez M; Barrio R; Sutherland JD; Rodríguez MS; Muñoz-Fontela C; Rivas C
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597768
[TBL] [Abstract][Full Text] [Related]
12. The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold.
Zhang AP; Bornholdt ZA; Liu T; Abelson DM; Lee DE; Li S; Woods VL; Saphire EO
PLoS Pathog; 2012 Feb; 8(2):e1002550. PubMed ID: 22383882
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24.
Kwofie SK; Broni E; Teye J; Quansah E; Issah I; Wilson MD; Miller WA; Tiburu EK; Bonney JHK
Comput Biol Med; 2019 Oct; 113():103414. PubMed ID: 31536833
[TBL] [Abstract][Full Text] [Related]
14. The Ebola virus VP24 protein prevents hnRNP C1/C2 binding to karyopherin α1 and partially alters its nuclear import.
Shabman RS; Gulcicek EE; Stone KL; Basler CF
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S904-10. PubMed ID: 21987768
[TBL] [Abstract][Full Text] [Related]
15. Evasion of interferon responses by Ebola and Marburg viruses.
Basler CF; Amarasinghe GK
J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
[TBL] [Abstract][Full Text] [Related]
16. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.
Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912
[TBL] [Abstract][Full Text] [Related]
17. Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses.
Pappalardo M; Juliá M; Howard MJ; Rossman JS; Michaelis M; Wass MN
Sci Rep; 2016 Mar; 6():23743. PubMed ID: 27009368
[TBL] [Abstract][Full Text] [Related]
18. Macrocyclic peptide inhibitors for the protein-protein interaction of Zaire Ebola virus protein 24 and karyopherin alpha 5.
Song X; Lu LY; Passioura T; Suga H
Org Biomol Chem; 2017 Jun; 15(24):5155-5160. PubMed ID: 28574091
[TBL] [Abstract][Full Text] [Related]
19. Quercetin Blocks Ebola Virus Infection by Counteracting the VP24 Interferon-Inhibitory Function.
Fanunza E; Iampietro M; Distinto S; Corona A; Quartu M; Maccioni E; Horvat B; Tramontano E
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366711
[TBL] [Abstract][Full Text] [Related]
20. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.
Mateo M; Carbonnelle C; Reynard O; Kolesnikova L; Nemirov K; Page A; Volchkova VA; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S1011-20. PubMed ID: 21987737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
